No black box warning on record for Gavilyte-N

As of the latest FDA labeling reviewed, Gavilyte-N (POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gavilyte-N medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities, arrhythmias, seizures and renal impairment– assess concurrent medications and consider testing in some patients ( 5.1 , 5.2 , 5.3 , 5.4 ) Patients with renal insufficiency– use caution, ensure adequate hydration and consider testing ( 5.4 ) Suspected GI obstruction or perforation – rule out the diagnosis before administration

No black box warning on record for Gavilyte-N

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities, arrhythmias, seizures and renal impairment– assess concurrent medications and consider testing in some patients ( 5.1 , 5.2 , 5.3 , 5.4 ) Patients with renal insufficiency– use caution, ensure adequate hydration and consider testing ( 5.4 ) Suspected GI obstruction or perforation – rule out the diagnosis before administration

Gavilyte-N Black Box Warning

No black box warning on record for Gavilyte-N

Other warnings & precautions

Gavilyte-N Black Box Warning

No black box warning on record for Gavilyte-N

Other warnings & precautions